| Company Name: | Agilent Technologies Inc | | Ticker Symbol: | A | | | WWW Address: | www.home.agilent.com |
| CEO: | Mr. William P. Sullivan | | No. of Employees: | 20,500 |
| Common Issue Type: | CS | | Business Description: | Agilent Technologies, Inc. provides core bio-analytical and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries.
|
| | | Industry Information: | HEALTH SERVICES - Medical Laboratories & Research [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 45.59 |  -0.15 | - | - | 45.36 | 45.69 | 45.25 | 2225361 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 15,827.0 | 347.2 | 1.52 | 3.27 | 0.30 | 15.8 | 1.1 | 47.47 - 35.32 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 45.59 | $ | | PE Ratio - LTM | 15.8 | |
| Market Capitalisation | 15,827.0 | mil |
| Latest Shares Outstanding | 347.2 | mil |
| Earnings pS (EPS) | 3.27 | $ |
| Dividend pS (DPS) | 0.30 | ¢ |
| Dividend Yield | 1.1 | % |
| Dividend Payout Ratio | 9 | % |
| Revenue per Employee | 334,537 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 343.2 | mil |
| Float as % of Shares Outstanding | 98.8 | % |
| Foreign Sales | 4,640 | mil |
| Domestic Sales | 2,218 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.90 | % |
| Research & Devlopment (R&D) as % of Revenue | 9.90 | % |
| Gross Profit Margin | 57.1 | % |
| EBITDA Margin | 20.3 | % |
| Pre-Tax Profit Margin | 14.2 | % |
| Assets Turnover | 0.7 | % |
| Return on Assets (ROA) | 1.7 | % |
| Return on Equity (ROE) | 3.3 | % |
| Return on Capital Invested (ROCI) | 2.4 | % |
| Current Ratio | 2.6 | |
| Leverage Ratio (Assets/Equity) | 2.0 | |
| Interest Cover | 1.6 | |
| Total Debt/Equity (Gearing Ratio) | 0.44 | |
| LT Debt/Total Capital | 28.0 | % |
| Working Capital pS | 8.26 | $ |
| Cash pS | 7.06 | $ |
| Book-Value pS | 15.41 | $ |
| Tangible Book-Value pS | 3.48 | $ |
| Cash Flow pS | 1.47 | $ |
| Free Cash Flow pS | -3.57 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.96 | |
| Price/Tangible Book Ratio | 13.10 | |
| Price/Cash Flow | 30.9 | |
| Price/Free Cash Flow | -12.8 | |
| P/E as % of Industry Group | 75.0 | % |
| P/E as % of Sector Segment | 60.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 01/16/2013 |
| Dividend Ex-Date | 03/27/2013 |
| Dividend Record Date | 04/01/2013 |
| Dividend Pay Date | 04/23/2013 |
| Dividend Amount | 120 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.48 |
| Current Dividend Yield | 1.1 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 9.0 |
| 5-Y Average Payout Ratio | 2.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.1 | 101 | 49,914 | 211,350 |
| 4 Weeks | 47.47 | 40.95 | 41.30 | 10.4 | 106 | 41,549 | 830,979 |
| 13 Weeks | 47.47 | 40.19 | 41.80 | 9.1 | 100 | 38,034 | 2,434,161 |
| 26 Weeks | 47.47 | 36.59 | 36.88 | 23.6 | 106 | 36,294 | 4,536,755 |
| 52 Weeks | 47.47 | 35.32 | 41.01 | 11.2 | 89 | 35,030 | 8,722,510 |
| YTD | 47.47 | 40.19 | - | 11.4 | 96 | 36,883 | 3,688,349 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 46.13 | 45.39 | 42.76 | 41.69 | 40.65 | 1.52 | 1.66 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 5.56 | 42.5 | 10.77 |
| Income | 0.00 | 0.0 | 44.28 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 33.49 | NA | 105.48 |
| R&D | -0.81 | NA | 2.19 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 1.3 | -0.1 | 3.7 |
| Earnings % | -28.9 | -34.9 | 0.0 |
| EPS % | -28.5 | -33.3 | 14.7 |
| EPS $ | -0.39 | -0.24 | 0.42 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 25.97 |
| Current Ratio | 2.4 |
| Quick Ratio (Acid Test) | 1.7 |
| Liquidity Ratio (Cash) | 1.24 |
| Receivables Turnover | 7.7 |
| Average Collection Period | 47 |
| Working Capital/Equity | 52.8 |
| Working Capital pS | 7.91 |
| Cash-Flow pS | 0.87 |
| Free Cash-Flow pS | -3.85 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.16 |
| Financial Leverage Ratio (Assets/Equity) | 2.0 |
| Debt Ratio | 50.8 |
| Total Debt/Equity (Gearing Ratio) | 0.46 |
| LT Debt/Equity | 0.41 |
| LT Debt/Capital Invested | 47.4 |
| LT Debt/Total Liabilities | 39.4 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 1.17 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 4.40 |
| Tobin's Q Ratio | 1.50 |
| Current P/E Ratio - LTM | 15.80 |
| Enterprise Value (EV)/EBITDA | 13.26 |
| Enterprise Value (EV)/Free Cash Flow | -15.25 |
| Dividend Yield | 1.1 |
| Price/Tangible Book Ratio - LTM | 13.10 |
| Price/Book Ratio - LTM | 2.96 |
| Price/Cash Flow Ratio | 30.9 |
| Price/Free Cash Flow Ratio - LTM | -12.8 |
| Price/Sales Ratio | 2.29 |
| P/E Ratio (1 month ago) - LTM | 14.8 |
| P/E Ratio (26 weeks ago) - LTM | 11.3 |
| P/E Ratio (52 weeks ago) - LTM | 13.2 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 75.0 |
| P/E as % of Sector Segment | 60.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 14.6 |
| PER SHARE FIGURES |
| LT Debt pS | 6.10 |
| Current Liabilities pS | 5.47 |
| Tangible Book Value pS - LTM | 3.48 |
| Book Value pS - LTM | 15.41 |
| Capital Invested pS | 21.01 |
| Cash pS - LTM | 7.06 |
| Cash Flow pS - LTM | 1.47 |
| Free Cash Flow pS - LTM | -3.57 |
| Earnings pS (EPS) | 3.27 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -19.44 |
| Free Cash Flow Margin 5YEAR AVG | -0.84 |
| Net Profit Margin | 0.0 |
| Net Profit Margin - 5YEAR AVRG. | 2.4 |
| Equity Productivity | 1.32 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 3.9 |
| Capital Invested Productivity | 0.94 |
| Return on Capital Invested (ROCI) | 0.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 2.4 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | 0.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 1.6 |
| Gross Profit Margin | 57.1 |
| Gross Profit Margin - 5YEAR AVRG. | 57.1 |
| EBITDA Margin - LTM | 20.3 |
| EBIT Margin - LTM | 15.7 |
| Pre-Tax Profit Margin | 15.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 12.3 |
| Effective Tax Rate | -10.5 |
| Effective Tax Rate - 5YEAR AVRG. | 110.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 165 |
| Revenue per Employee | 334,537 |
| Net Income per Employee | |
| Average Collection Period | 48 |
| Receivables Turnover | 7.7 |
| Day's Inventory Turnover Ratio | 117 |
| Inventory Turnover | 3.1 |
| Inventory/Sales | 14.8 |
| Accounts Payble/Sales | 6.72 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 2.51 |
| Fixed Assets Turnover | 1.16 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 2.92 |
| Revenue per $ Plant | 5.89 |
| Revenue per $ Common Equity | 1.32 |
| Revenue per $ Capital Invested | 0.94 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 29.7 |
| Research & Devlopment (R&D) as % of Revenue | 9.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 9.7 |
|
|  
| | |  |  | |
| |
